With the close of 2024 and the launch of a new year, we can take a moment to look back at what was another eventful, ...

As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...

One is that investors are going to continue to look for opportunities where generative AI or just the requirements to supply ...

The activation marked the latest phase of the ongoing It Takes 2 campaign from Boehringer Ingelheim and Eli Lilly.

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

We recently compiled a list of the Billionaire Israel Englander’s Top 10 Stock Picks Heading Into 2025. In this article, we ...

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...

Patricia Clarkson is forgettable in tonally confusing 'Lilly,' full of intrusively edited archival material and curious ...

Lloyd Payne: It’s no secret that Concord continues to be a fast-growing city with record economic growth and an increasingly ...

Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for ...

PharmStars is accepting applications for its eighth cohort since CEO Naomi Fried founded it four years ago, revolving around ...

On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...